Should you buy M&M, OIL, BHEL, Zomato, Crompton Greaves, other stocks today? Here is what brokerages recommend

As Dalal Street enters the February 15 session, brokerages have several stocks on their radar.

Should you buy M&M, OIL, BHEL, Zomato, Crompton Greaves, other stocks today?

As Dalal Street enters the February 15 session, brokerages have several stocks on their radar. Here's what Goldman Sachs, Jefferies, Macquarie, JPMorgan, Citi, Morgan Stanley, CLSA, HSBC and Nomura make of stocks such as Mahindra & Mahindra (M&M), Oil India Ltd (OIL), Bharat Heavy Electricals Ltd (BHEL), Zomato and Crompton Greaves Consumer Electricals Ltd:

M&M share price target:

Four brokerages, CLSA, Citi, HSBC and Nomura have maintained 'buy' ratings on the Mahindra & Mahindra (M&M) stock with targets of Rs 2,074, Rs 1,890, Rs 1,900 and Rs 2,143, respectively.

Jefferies has maintained a 'hold' call on the stock with a target of Rs 1,615

TRENDING NOW

Both JPMorgan and Morgan Stanley have maintained their 'overweight' ratings on M&M shares with targets of Rs 1,880 and Rs 1,952, respectively.

Macquarie has maintained an 'outperform' rating on M&M with a target of Rs 1,801.

ABFRL share price target:

Morgan Stanley has maintained an 'underweight' rating on the Aditya Birla Fashion and Retail (ABFRL) stock with a target of Rs 176.

Crompton share price target:

Morgan Stanley has maintained an 'equal-weight' rating on the Crompton Greaves Consumer Electricals Ltd stock with a target of Rs 281.

Macquarie has maintained an 'outperform' rating on the Crompton shares with a target of Rs 329.

Nomura has maintained a 'neutral' rating on Crompton Greaves shares with a target of Rs 321.

Muthoot Finance share price target:

CLSA has maintained a 'reduce' rating on the Muthoot Finance stock with a target of Rs 1,440.

Morgan Stanley has maintained an 'underweight' rating on Muthoot Finance shares with a target of Rs 1,165.

Zomato share price target:

CLSA has maintained a 'buy' call on the Zomato stock with a target of Rs 227.

Gland Pharma share price target:

Both Jefferies and Goldman Sachs have maintained 'buy' ratings on the Gland Pharma stock with targets of Rs 2,400 and Rs 2,125, respectively.

On the other hand, Citi has maintained a 'sell' call on the stock with a target of Rs 1,310.

Nomura has maintained a 'neutral' rating on the Gland Pharma shares with a target of Rs 1,570.

BHEL share price target:

Morgan Stanley has an 'equal-weight' rating on the Bharat Heavy Electricals Ltd (BHEL) stock with a target of Rs 220.

Prestige Estates share price target:

CLSA has a 'buy' call on the Prestige Estates Projects stock with a target of Rs 1,440.

Citi has maintained a 'buy' call on Prestige Estates shares with a target of Rs 1,281.

Morgan Stanley has maintained an 'overweight' rating on Prestige Estates with a target of Rs 1,300, while Jefferies has maintained an 'underperform' rating on the stock with a target of Rs 985.